BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dominick F, van Laarhoven AI, Evers AW, Weisshaar E. A systematic review of questionnaires on itch by the Special Interest Group “Questionnaires” of the International Forum for the Study of Itch (IFSI). Itch 2019;4:e26-e26. [DOI: 10.1097/itx.0000000000000026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Okubo Y, Takahashi H, Hino R, Endo K, Kikuchi S, Ozeki Y, Nakamura T, Paris M, Abe M. Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study. Dermatol Ther (Heidelb) 2022;12:1469-80. [PMID: 35689737 DOI: 10.1007/s13555-022-00747-5] [Reference Citation Analysis]
2 Gabes M. The 'Chronic Itch Burden Scale': giving patients with chronic pruritus a voice. Br J Dermatol 2021. [PMID: 34632566 DOI: 10.1111/bjd.20714] [Reference Citation Analysis]
3 Theunis J, Nordon C, Falissard B, Orri M, Mengeaud V, Misery L. Development and preliminary validation of the patient-reported Chronic Itch Burden Scale assessing health-related quality of life in chronic pruritus. Br J Dermatol 2021. [PMID: 34128535 DOI: 10.1111/bjd.20582] [Reference Citation Analysis]
4 Weng HJ, Shih MH, Tsai TF, Song YC, Pan YC, Hu JY, Chung-Yee Hui R, Lee WR, Huang YH, Liu SH. Clinical validation and utility of Chinese Eppendorf Itch Questionnaire in adults with chronic pruritus symptoms. J Formos Med Assoc 2021;120:492-500. [PMID: 32600865 DOI: 10.1016/j.jfma.2020.06.022] [Reference Citation Analysis]